• Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
This article has been cited by
1The role of immunotherapy in small cell lung cancer
A. Calles,G. Aguado,C. Sandoval,R. Álvarez
Clinical and Translational Oncology.2019;21(8)961
[DOI]
2Pharmacokinetics and Systems Pharmacology of Anti-CD47 Macrophage Immune Checkpoint Inhibitor Hu5F9-G4
Adarsh Mishra,Ishant Kataria,Sujit Nair
Current Pharmacogenomics and Personalized Medicine.2020;17(1)14
[DOI]
3Lipid-based phagocytosis nanoenhancer for macrophage immunotherapy
Anujan Ramesh,Sahana Kumar,Anh Nguyen,Anthony Brouillard,Ashish Kulkarni
Nanoscale.2020;12(3)1875
[DOI]
4Immune checkpoints in tumor microenvironment and their relevance to the development of cancer stem cells
Neda Khosravi,Ahad Mokhtarzadeh,Amir Baghbanzadeh,Khalil Hajiasgharzadeh,Vahid Khaze Shahgoli,Nima Hemmat,Elham Safarzadeh,Behzad Baradaran
Life Sciences.2020;256(3)118005
[DOI]
5Realizing the Clinical Potential of Immunogenic Cell Death in Cancer Chemotherapy and Radiotherapy
Bernardo Rapoport,Ronald Anderson
International Journal of Molecular Sciences.2019;20(4)959
[DOI]
6Monoclonal Antibodies for the Treatment of Multiple Myeloma: An Update
Hanley Abramson
International Journal of Molecular Sciences.2018;19(12)3924
[DOI]
7Unexpected therapeutic effects of cisplatin
Martina Raudenska,Jan Balvan,Michaela Fojtu,Jaromir Gumulec,Michal Masarik
Metallomics.2019;11(7)1182
[DOI]
8Immune checkpoint inhibitors in multiple myeloma: A review of the literature
Santino Caserta,Vanessa Innao,Caterina Musolino,Alessandro Allegra
Pathology - Research and Practice.2020;216(10)153114
[DOI]

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal